Table 1 Demographic data of patients who underwent emergent pancreaticoduodenectomy for non-traumatic etiologies in our series
From: The impact of preoperative etiology on emergent pancreaticoduodenectomy for non-traumatic patients
Sex/age/indication | Cancer | Procedure/blood loss (ml) | APACHE II score/BMI/Hb (g/dL)/albumin (g/dL) | Complication/grading | Death | Hospital stay (days) |
|---|---|---|---|---|---|---|
M/70/internal bleeding after partial pancreatectomy | No | CW/1000 | 17/18.6/13.6/4.9 | Bile leakage/2 | No | 109 |
M/49/bleeding duodenal lymphoma | Lymphoma | CW/20 | 16/20.1/11/2.2 | P-duct leakage with Peritonitis/3 | No | 54 |
F/78/A-loop perforation after ERCP | GC | CW/400 | 12/21.3/9.4/3.3 | MOF/4 | Yesa | 16 |
F/58/A-loop obstruction and perforation | No | CW/500 | 6/17.3/11.9/3.2 | Retro-peritoneal infection/3 | No | 17 |
M/32/bowel ischemia | No | CW/2850 | 19/24.3/11.3/1.9 | Septic shock with liver and renal failure/5 | Yes | 11 |
F/39/duodenal ulcer bleeding | No | CW/1000 | 17/19.5/4.5/2.2 | Wound infection/2 | No | 40 |
53.5 | 750 | 16.5/19.8/11.2/2.7 | 28.5 |